Back to results
US 2020/0345739 A1Published application
SMALL MOLECULE NF-kB INHIBITORS
AssigneeImmuneTarget, Inc.
InventorsSamedy Ouk, Hsiou-Chi Liou
Life of this patent
Estimating the term…
Abstract
The present invention provides, inter alia, compounds capable of inhibiting NF-κB. Pharmaceutical compositions containing and methods of using the compounds are also provided herein.
Claims1
A method of inhibiting NF-κB in a cell, comprising:
- contacting the cell with a compound, wherein the compound is selected from the group consisting of
- and hydrates or pharmaceutically acceptable salts thereof.
Dependencies are inferred from the claim text.